AI Summary (3-min read)
TLDR
This episode explores the real-world impact of GLP-1 drugs like Ozempic and Wegovy through the perspective of Dr. Rachel Bedard, a physician who works with underserved populations at a homeless clinic in Brooklyn. While public discourse fixated on celebrity use and moral debates about wei
This episode explores the real-world impact of GLP-1 drugs like Ozempic and Wegovy through the perspective of Dr. Rachel Bedard, a physician who works with underserved populations at a homeless clinic in Brooklyn. While public discourse fixated on celebrity use and moral debates about wei
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.
Guest
R
Rachel Bedard
conversational on Search Engine
Mentions
Books, people, and resources mentioned in this episode.
People
Rachel Bedard
Companies
Novo Nordisk
Products & Tools
OzempicWegovyZepboundMounjarosemaglutidetirzepatide
Research & Papers
Alzheimer's prevention trial with GLP-1s
Topics
AddictionBiohackingFitnessHormonesLongevityMental HealthNutritionWeight LossWomens Health
Listen to This Episode
Get summaries like this every morning.
Free AI-powered recaps of Search Engine and your other favorite podcasts, delivered to your inbox.
Get Free Summaries →
Free forever for up to 3 podcasts. No credit card required.